Can Fite Biopharma Ltd (CANF) — Cash Flow-to-Debt Ratio
Can Fite Biopharma Ltd (CANF) has a Cash Flow-to-Debt Ratio of -0.67x as of June 2025, meaning its operating cash flow of ILA-2.38 Million could theoretically repay -1% of its total liabilities (ILA3.54 Million) in one year. Explore how much of Can Fite Biopharma Ltd's assets are long-term investments to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Can Fite Biopharma Ltd Cash Flow-to-Debt Ratio (2010–2025)
Historical debt coverage capacity for Can Fite Biopharma Ltd across 16 annual periods. Also explore how large is Can Fite Biopharma Ltd's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Can Fite Biopharma Ltd (2010–2025)
Year-by-year debt coverage analysis for Can Fite Biopharma Ltd. For market capitalisation and broader financial context, see market value of Can Fite Biopharma Ltd.
| Year | CF-to-Debt Ratio | Operating CF (ILA) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.47x | ILA-9.69 Million | ILA3.92 Million | ▼ -19.1% |
| 2024 | -2.07x | ILA-7.64 Million | ILA3.68 Million | ▲ +8.0% |
| 2023 | -2.25x | ILA-8.44 Million | ILA3.75 Million | ▼ -0.4% |
| 2022 | -2.25x | ILA-10.80 Million | ILA4.81 Million | ▼ -33.7% |
| 2021 | -1.68x | ILA-9.86 Million | ILA5.87 Million | ▲ +52.0% |
| 2020 | -3.50x | ILA-12.06 Million | ILA3.45 Million | ▼ -85.0% |
| 2019 | -1.89x | ILA-10.83 Million | ILA5.73 Million | ▼ -124.6% |
| 2018 | -0.84x | ILA-4.16 Million | ILA4.94 Million | ▲ +57.8% |
| 2017 | -1.99x | ILA-9.52 Million | ILA4.78 Million | ▼ -40.5% |
| 2016 | -1.42x | ILA-8.93 Million | ILA6.29 Million | ▼ -118.2% |
| 2015 | -0.65x | ILA-4.65 Million | ILA7.16 Million | ▲ +70.5% |
| 2014 | -2.20x | ILA-7.33 Million | ILA3.33 Million | ▲ +44.5% |
| 2013 | -3.97x | ILA-8.63 Million | ILA2.18 Million | ▼ -113.7% |
| 2012 | -1.86x | ILA-4.35 Million | ILA2.34 Million | ▲ +45.6% |
| 2011 | -3.41x | ILA-5.50 Million | ILA1.61 Million | ▼ -410.8% |
| 2010 | -0.67x | ILA-3.65 Million | ILA5.47 Million | — |